Trends in racial/ethnic and geographic disparities in substance use disorders mortality in the United States, 2000-2019 [0.03%]
2000至2019年美国物质使用障碍死亡率的种族、民族和地区差异趋势
Akshaya S Bhagavathula,Theodoros Daglis,Yoshito Nishimura
Akshaya S Bhagavathula
Background and objectives: Substance use disorders (SUD) are a major public health concern in the United States. This study examined racial/ethnic and state-level disparities in SUD mortality in the United States from 200...
Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era [0.03%]
新形势下的应对策略：芬太尼时代下成瘾医学专家对阿片类药物使用障碍治疗和政策挑战的看法
Jeremy Weleff,Nicholaus J Christian,James X Wang et al.
Jeremy Weleff et al.
Background and objectives: Amidst increasing opioid-related overdoses in the USA, opioid use disorder (OUD) treatment has seen few novel treatments emerge. High-potency synthetic opioids (HPSOs) have altered clinical appr...
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity? [0.03%]
度冷丁剂量与新生儿爆发力的关系吗？
Besnier Marc,Delouche Marion,Birault François et al.
Besnier Marc et al.
Background: Neonatal opioid withdrawal syndrome (NOWS) is a drug withdrawal syndrome occurring mainly after in utero opioid exposure. Buprenorphine is commonly used for opioid withdrawal. Studies are conflicted about a po...
Association between state-level medical marijuana legalization and marijuana use during pregnancy: A population-based study [0.03%]
关于大麻合法化与孕期使用大麻的关联：一项基于人口的队列研究
Mohammad Rifat Haider,Sabrina Karim,Jayani Jayawardhana et al.
Mohammad Rifat Haider et al.
Background and objectives: Despite marijuana's association with adverse pregnancy and birth outcomes, its use during pregnancy increased over the last two decades. During this period, medical marijuana has been legalized ...
Alyssa Vanderziel,James C Anthony,David Barondess et al.
Alyssa Vanderziel et al.
Background and objectives: Prenatal cannabis use prevalence in the United States has increased. Relaxation of state-level cannabis policy may be contributing to the diminished risk perception of using cannabis. The main p...
Health care service utilization and drug overdose death: A national nested case-control registry study [0.03%]
医疗保健利用与药物过量死亡：全国嵌套病例对照登记研究
Linn Gjersing,Ellen J Amundsen
Linn Gjersing
Background and objectives: More knowledge is needed to identify and reach those at overdose risk with preventive measures. We examined past 12-month health service utilization, identified the most frequently utilized serv...
Alcohol use disorder, cannabis use disorder, and eating disorder symptoms among male and female college students [0.03%]
大学生饮酒障碍、大麻使用障碍和进食障碍的症状性别差异研究
Eric R Pedersen,Ireland M Shute,Keegan D Buch et al.
Eric R Pedersen et al.
Background and objectives: Eating disorders (EDs) and substance use disorders are prevalent among college students in the United States, with underlying common mechanisms suggesting co-occurrence of these in the student p...
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study [0.03%]
关于丁丙诺啡HCl(BXCL501)作为治疗酒精使用障碍及共病创伤后应激障碍潜在药物的研究：一项一期b阶段、安慰剂对照交叉实验室研究
Ismene L Petrakis,Tracy Nolen,Nathan Vandergrift et al.
Ismene L Petrakis et al.
Background and objectives: Noradrenergic dysregulation is important in the pathophysiology of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD); pharmacotherapies targeting adrenergic function have poten...
Clinical Trial
The American journal on addictions. 2025 Jan;34(1):7-14. DOI:10.1111/ajad.13637 2025
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial [0.03%]
一项实用主义加拿大全国随机对照试验中既往有非致命性过量用药史的个体使用阿片受体激动剂治疗的效果：研究结果
Hannah Crepeault,Lianping Ti,Paxton Bach et al.
Hannah Crepeault et al.
Background and objectives: History of nonfatal overdose (NFO) is common among people who use opioids, but little is known about opioid agonist treatment (OAT) outcomes for this high-risk subpopulation. The objective of th...
Randomized Controlled Trial
The American journal on addictions. 2025 Jan;34(1):50-59. DOI:10.1111/ajad.13635 2025
State-level racial and ethnic disparities in buprenorphine treatment duration in the United States [0.03%]
美国各州种族和族裔在丁丙诺啡治疗持续时间上的差异
Huiru Dong,Erin J Stringfellow,Mohammad S Jalali
Huiru Dong
Background and objectives: National trends reveal a concerning escalation in racial and ethnic disparities in buprenorphine treatment duration for opioid use disorder. However, the extent of such disparities at the state ...